Observational studyFrontiers in immunology2022

Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan.

Yosuke Kunishita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.